Live
Merck & Co.Merck & Co. Inc. stock (US58933Y1055): Earnings beat and pipeline update drive investor interest - AD HOC NEWSMettler ToledoMettler Toledo (MTD) Margin Slippage Tests Bullish Earnings Growth Narratives - simplywall.stLabCorpLabcorp stock (US50540R4092): Diagnostic and drug development leader in focus for US investors - AD HOC NEWSCellFerroptosis inhibition enhances liver and lung graft functionCell<em>Streptomyces</em> enrichment in roots during drought is uncoupled from plant benefit and is driven by host suppression of iron uptake and immunityCellAI-predicted spatial transcriptomics unlocks breast cancer biomarkers from pathologyCellMultimodal clocks of human agingCellThe rise of polyploids during environmental upheavalMerck KGaAMerck KGaA stock (DE0006599905): Pharma and tech group eyes growth in US markets - AD HOC NEWSCharles RiverCharles River Laboratories stock (US1591881009): Shares dip after recent run-up as analysts eye upsi - AD HOC NEWSEurofinsEurofins Scientific SE stock (FR0014000MR3): Lab testing group eyes growth amid regulatory shifts an - AD HOC NEWSEndpoints NewsBiotech’s new company model; The super poop behind a startup launch; and more
BioPharma Dive Mar 25, 2026

Sarepta sees early success with RNAi drugs from Arrowhead

Sarepta sees early success with RNAi drugs from Arrowhead

Original
Body unavailable. Use the original source.